Top

Published in:

01-04-2009 | Editorial

On track to limit antifungal overuse!

Authors: Philippe Eggimann, Frédéric Lamoth, Oscar Marchetti

Published in: Intensive Care Medicine | Issue 4/2009

Excerpt

Invasive candidiasis (IC) has emerged as a main cause of morbidity and mortality among critically ill patients. Candida colonization at multiple sites promoted by prolonged exposure to antibiotics, intravascular devices for parenteral nutrition or renal replacement therapy, and complicated abdominal surgery are associated with the development of IC [1]. The gastrointestinal tract and endovascular catheters are thus the most common sources of IC [2]. …

Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patient. Lancet Infect Dis 3:685–702PubMedCrossRef

Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967PubMedCrossRef

Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, Kontoyiannis D, Darouiche R, Hachem R, Bodey GP (2004) Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38:1119–1127PubMedCrossRef

Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25–31PubMedCrossRef

Prella M, Bille J, Pugnale M, Duvoisin B, Cavassini M, Calandra T, Marchetti O (2005) Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 51:95–101PubMedCrossRef

Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, Marchetti O (2008) 1, 3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46:878–885PubMedCrossRef

Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, EPCAN Study Group (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRef

Eggimann P, Garbino J, Pittet D (2003) Management of Candida species infections in critically ill patient. Lancet Infect Dis 3:772–785PubMedCrossRef

Mean M, Marchetti O, Calandra T (2008) Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 12:204PubMedCrossRef

10.

Pfaller MA, Diekema DJ, Gibbs DL (2007) Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45:1735–1745PubMedCrossRef

11.

Brion LP, Uko SE, Goldman DL (2007) Risk of resistance associated with fluconazole prophylaxis: systematic review. J Infect 54:521–529PubMedCrossRef

12.

Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sá M, Johnson EM, Müller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med. doi:10.1007/s00134-008-1339-6

13.

Playford EG, Eggimann P, Calandra T (2008) Antifungals in the ICU. Curr Opin Infect Dis 21:610–619PubMedCrossRef

14.

Rex JH. http://www.uncedu/~churt/id_cc_ppts/IDSA_Candidiasis_Rex ppt. Accessed 9th Jan 2009

15.

Forrest GN, Weekes E, Johnson JK (2008) Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 56:126–129PubMedCrossRef

16.

Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P (2008) Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Int J Antimicrob Agents 32:511–514PubMedCrossRef

17.

Pérez-Parraz A, Munoz P, Guinea J, Martin-Rabadan P, Guembe M, Bouza E (2009) Is Candida colonization of central vascular catheter in non-candidemic, non-neutropenic patients an indicator for antifungals? Intensive Care Med. doi:10.1007/s00134-009-1431-6

18.

Eggimann P (2007) Diagnosis of intravascular catheter infection. Curr Opin Infect Dis 20:353–359PubMedCrossRef

Title: On track to limit antifungal overuse!
Authors: Philippe Eggimann
Frédéric Lamoth
Oscar Marchetti
Publication date: 01-04-2009
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 4/2009
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-009-1432-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

On track to limit antifungal overuse!

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2009

Controversies in paediatric continuous renal replacement therapy

Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU

Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis

Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model

Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study

Lack of agreement between arterial and central venous blood glucose measurement in critically ill children